Telescope Innovations Ships First Samples of Battery-Grade Lithium Sulfide
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a leader in intelligent automation platforms for accelerating chemical process development, today announced a key milestone in the commercial advancement of its lithium sulfide (Li₂S) production platform, DualPure ™.The Company has shipped its first battery-grade Li₂S samples to leading battery industry groups in Asia and North America as part of its commercial development program. These shipments...
2025-05-07 8:00 AM EDT
Telescope Innovations Presents Results of Second Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2025 (Q2). The Company generated revenues of $1.0 million during this quarterly period, and an adjusted EBITA loss of $0.4 million. Telescope continues to strategically reinvest revenues to drive operational growth, and...
2025-04-23 11:56 PM EDT
Telescope Innovations to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 2:00-2:30 PM (Local Time - PST). Chief Operating Officer, Dr. Jeffrey W. Sherman...
2025-04-14 3:17 PM EDT
Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company is pleased to provide an update on its Self-Driving Lab ("SDL") technology, which integrates AI, robotics, advanced analytics, and chemistry to accelerate research and development.Recent AI advancements highlight that ingenuity and adaptability-not just scale-drive innovation. Companies that...
2025-02-24 3:05 AM EST
Telescope Innovations Commences Trading on the Frankfurt Stock Exchange
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations", "Telescope", or the "Company") is pleased to announce that its common shares are now listed for trading on the Frankfurt Stock Exchange ("FSE") under the ticker symbol "J4U".With this listing, Telescope Innovations expands its visibility and accessibility to European investors. The Frankfurt Stock Exchange is one of the world's largest and most active trading venues, providing access to institutional and retail investors...
2025-02-19 3:05 AM EST
Telescope Innovations Founder and CTO, Professor Jason Hein, Honoured with 2025 R. U. Lemieux Award
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company is pleased to announce that its Founder and Chief Technology Officer, Professor Jason Hein, has been awarded the prestigious 2025 R.U. Lemieux Award by the Chemical Institute of Canada. This award recognizes Professor Hein's contributions to organic chemistry and his pioneering...
2025-02-10 8:00 AM EST
Telescope Innovations Presents Results of First Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2024 (Q1). The Company generated revenues of $1.2 million during this period, driven by strong sales performance and market adoption of its flagship product, DirectInject-LC™, and an adjusted EBITA loss of $103K. Revenues have been strategically...
2025-01-27 6:13 PM EST
Telescope Innovations Demonstrates Production of >99% Pure Lithium Carbonate from Widely Varied North American Brines
Telescope’s proprietary ReCRFT™ process paves the way for on-shore production of battery raw materialsVancouver, British Columbia--(Newsfile Corp. - January 13, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcomes of its Brine-to-Battery Program. Over the past year, Telescope Innovations' proprietary ReCRFT™ recrystallization technology has produced battery-grade (>99% pure) lithium carbonate from a wide variety of North...
2025-01-13 8:00 AM EST
Telescope Innovations Presents Continued Growth in Fiscal Year 2024
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal year ended August 31, 2024. The Company generated revenues of $4.4 million during this period, with an Adjusted EBITDA loss of $152 K (Figure 1). Revenues have been strategically reinvested to drive team growth and enhanced capacity for both R&D...
2024-12-23 6:00 PM EST
Telescope Innovations Announces Scientific Publication on AI-Optimized Production of Battery-Grade Lithium Carbonate
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to announce the publication of a collaborative research project in Digital Discovery. The peer-reviewed paper, "Artificial Intelligence-Enabled Optimization of Battery-Grade Lithium Carbonate Production", introduces a cutting-edge AI-driven method to increase the yield of lithium carbonate produced from lithium brine concentrates.1 The work provides a...
2024-10-29 8:00 AM EDT
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, announces its achievement of Certified Systems Integrator ("CSI") status for robotic instruments sold by Universal Robots ("UR"). UR has emerged as a global provider of collaborative robots for manufacturing and production automation, as well as for integration with artificial intelligence ("AI"). Telescope Innovations has used...
2024-10-15 8:00 AM EDT
Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research engagement with Altillion, Inc. ("Altillion") an innovator in lithium brine processing.During this project, Telescope Innovations applied its proprietary ReCRFT™ recrystallization technology to lithium-containing brines that had been concentrated via Altillion's novel ALIX process. The resulting lithium carb
2024-09-17 8:00 AM EDT
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome of a research collaboration with Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) ("Standard Lithium").Over the past year, Telescope Innovations and Standard Lithium have worked together to develop a new method for producing high-purity lithium sulfide, a key material needed...
2024-08-28 8:00 AM EDT
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the execution of a master collaborative research agreement (the "Agreement") with Pfizer Inc. ("Pfizer"). Under the multi-year Agreement, Pfizer and Telescope will collaboratively develop technology to help potentially accelerate pharmaceutical R&D through automation, robotics, and artificial intelligence.Certain technology development efforts will focus...
2024-07-31 8:00 AM EDT
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage funding from the B.C. Centre for Innovation and Clean Energy ("CICE"). This non-dilutive investment will support Telescope's piloting of its proprietary Recrystallization Refinement Technology ("ReCRFT™"): a carbon-negative and low-cost method to produce battery-grade lithium carbonate from saltwater brines. ReCRFT is...
2024-07-22 1:43 PM EDT
Telescope Innovations Presents Results of Third Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended May 31, 2024. The Company generated revenues of $1.2 million during this period (Q3, 2024). Telescope's corresponding fiscal year-to-date revenues exceed $3.4 million and surpass the amount for the entire previous fiscal year (Figure 1).
2024-07-11 8:37 PM EDT
Telescope Innovations Joins MaRS: North America's Largest Urban Innovation Hub
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member of MaRS Discovery District, ("MaRS") a network of the most promising and innovative young technology companies in Canada. As North America's largest urban innovation hub, MaRS empowers member companies to generate economic growth, technology adoption, and impact through advisory services,...
2024-06-24 8:00 AM EDT
Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation the 2024 Lithium Supply and Battery Raw Materials Conference hosted by Fastmarkets. The conference will take place on June 24-27 in Las Vegas, NV. Dr. Ryan Jansonius, VP of Chemistry Contract Services for the Company, and Jeffrey Sherman, COO,...
2024-06-11 8:00 AM EDT
Telescope Innovations to Showcase DirectInject-LC(TM) Product and Process IP at METTLER TOLEDO Events
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation in two "InfoDays" sponsored by METTLER TOLEDO. Telescope will feature two proprietary innovations during the New Jersey and Montreal InfoDays. InfoDays are high-profile industry and academia networking events focused on innovative automation approaches to synthetic chemistry and process manufacturing. 2024...
2024-05-13 8:00 AM EDT
Telescope Innovations Presents Results of Second Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results and operational highlights for the fiscal quarter ended February 29, 2024. The Company generated revenues of $686,205 during this period, driven by strong sales performance of its flagship product, DirectInject-LC™. Operational highlights during the quarter include new intellectual property, global distribution of Telescope's...
2024-04-18 8:02 PM EDT